{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:46:16Z","timestamp":1791899176080,"version":"4.3.4"},"reference-count":40,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"\n OBJECTIVE<\/jats:title>\n To evaluate feasibility and diagnostic and process qualities as well as the clinical benefit of newborn screening (NBS) for urea cycle disorders (UCDs).<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n Between 2016 and 2023, 624\u2009480 neonates were enrolled in the German NBS pilot study, including NBS for UCDs by tandem mass spectrometry. In addition, patients with confirmed cases were enrolled in an observational, multicenter outcome study assessing clinical and neurodevelopmental outcomes.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n NBS for UCDs demonstrated high sensitivity (100%) and specificity (99.988%) with a positive predictive value (PPV) of 0.2. Nineteen cases (7 ornithine transcarbamoylase deficiency, 7 argininosuccinate synthetase 1 deficiency, 4 argininosuccinate lyase deficiency, and 1 carbamoylphosphate synthetase 1 deficiency) were confirmed, yielding a cumulative birth prevalence of 1:32\u2009867 newborns. Despite short process times, more than 50% of screened individuals with a UCD were already symptomatic at first NBS report. Retrospective analyses indicated that integration of metabolite ratios (eg, ornithine\/citrulline) may further enhance PPV. Outcome data from 25 individuals revealed higher rates of metabolic decompensations and hospitalizations in mitochondrial UCDs vs cytosolic forms. At last follow-up, 55% showed disease-related symptoms, and mean IQ was reduced in symptomatic individuals, but mortality was lower than previously reported.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSION<\/jats:title>\n NBS for UCDs is technically feasible and enables early diagnosis. Although early-onset decompensations remain difficult to prevent, screening reduces mortality. Refinement of the screening algorithm may further improve specificity and clinical benefit.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.2025-074052","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:02:47Z","timestamp":1784678567000},"source":"Crossref","is-referenced-by-count":0,"title":["Newborn Screening for Urea Cycle Disorders and Clinical Outcomes"],"prefix":"10.1542","volume":"158","author":[{"given":"Svenja","family":"Scharre","sequence":"first","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen G.","family":"Okun","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Gleich","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Feyh","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Kessler","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Haas","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Posset","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Schnabel-Besson","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Mengler","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Reischl-Hajiabadi","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Zielonka","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"H\u00f6rster","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Fang-Hoffmann","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Morath","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn","family":"Gramer","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"},{"name":"3Department for Inborn Metabolic Diseases, University Children\u2019s Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Freisinger","sequence":"additional","affiliation":[{"name":"4Children\u2019s Hospital Reutlingen, Klinikum am Steinenberg, Reutlingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia B.","family":"Hennermann","sequence":"additional","affiliation":[{"name":"5Villa Metabolica, Center for Pediatric and Adolescent Medicine, Mainz University Medical Center, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Kr\u00e4mer","sequence":"additional","affiliation":[{"name":"6Department of Pediatric and Adolescent Medicine, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Thimm","sequence":"additional","affiliation":[{"name":"7Department of General Pediatrics, Neonatology, and Pediatric Cardiology, University Children\u2019s Hospital, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gr\u00fcnert","sequence":"additional","affiliation":[{"name":"8Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Schumann","sequence":"additional","affiliation":[{"name":"8Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg F.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Janda","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven F.","family":"Garbade","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00f6lker","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"M\u00fctze","sequence":"additional","affiliation":[{"name":"1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany"},{"name":"2Clinic I, Division of Pediatric Neurology and Metabolic Medicine, Centre for Pediatric and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"1\u20132","key":"2026101308522408600_r1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol Genet Metab."},{"issue":"1","key":"2026101308522408600_r2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-017-0661-x","article-title":"Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland","volume":"12","author":"Nettesheim","year":"2017","journal-title":"Orphanet J Rare Dis."},{"issue":"1\u20132","key":"2026101308522408600_r3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol Genet Metab."},{"issue":"6","key":"2026101308522408600_r4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation","volume":"38","author":"K\u00f6lker","year":"2015","journal-title":"J Inherit Metab Dis."},{"issue":"6","key":"2026101308522408600_r5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype","volume":"38","author":"K\u00f6lker","year":"2015","journal-title":"J Inherit Metab Dis."},{"issue":"6","key":"2026101308522408600_r6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"H\u00e4berle","year":"2019","journal-title":"J Inherit Metab Dis."},{"issue":"2","key":"2026101308522408600_r7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ijns10020038","article-title":"Current status of newborn bloodspot screening worldwide 2024: a comprehensive review of recent activities (2020\u20132023)","volume":"10","author":"Therrell","year":"2024","journal-title":"Int J Neonatal Screen."},{"key":"2026101308522408600_r8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejpn.2025.03.017","article-title":"Newborn screening for neuro-metabolic disorders: strategies, clinical benefits, and prerequisites for program expansion","volume":"56","author":"M\u00fctze","year":"2025","journal-title":"Eur J Paediatr Neurol."},{"issue":"1","key":"2026101308522408600_r9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ymgme.2010.01.013","article-title":"Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria","volume":"100","author":"Mercimek-Mahmutoglu","year":"2010","journal-title":"Mol Genet Metab."},{"issue":"2","key":"2026101308522408600_r10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2018.04.006","article-title":"Newborn screening for proximal urea cycle disorders: current evidence supporting recommendations for newborn screening","volume":"124","author":"Merritt","year":"2018","journal-title":"Mol Genet Metab."},{"issue":"4","key":"2026101308522408600_r11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ymgme.2020.10.013","article-title":"Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders","volume":"131","author":"Posset","year":"2020","journal-title":"Mol Genet Metab."},{"issue":"5","key":"2026101308522408600_r12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jpba.2009.03.001","article-title":"Hypocitrullinemia in expanded newborn screening by LC-MS\/MS is not a reliable marker for ornithine transcarbamylase deficiency","volume":"49","author":"Cavicchi","year":"2009","journal-title":"J Pharm Biomed Anal."},{"issue":"3","key":"2026101308522408600_r13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/jimd.12331","article-title":"The role of orotic acid measurement in routine newborn screening for urea cycle disorders","volume":"44","author":"Staretz-Chacham","year":"2021","journal-title":"J Inherit Metab Dis."},{"issue":"6","key":"2026101308522408600_r14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00431-003-1188-9","article-title":"Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation","volume":"162","author":"Bachmann","year":"2003","journal-title":"Eur J Pediatr."},{"issue":"1","key":"2026101308522408600_r15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.25492","article-title":"Impact of diagnosis and therapy on cognitive function in urea cycle disorders","volume":"86","author":"Posset","year":"2019","journal-title":"Ann Neurol."},{"issue":"4","key":"2026101308522408600_r16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ijns6040077","article-title":"Considering proximal urea cycle disorders in expanded newborn screening","volume":"6","author":"Vasquez-Loarte","year":"2020","journal-title":"Int J Neonatal Screen."},{"key":"2026101308522408600_r17","author":"University Hospital Heidelberg"},{"issue":"6","key":"2026101308522408600_r18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1542\/peds.111.6.1399","article-title":"Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications","volume":"111","author":"Schulze","year":"2003","journal-title":"Pediatrics."},{"issue":"4","key":"2026101308522408600_r19","doi-asserted-by":"crossref","first-page":"e2024068293","DOI":"10.1542\/peds.2024-068293","article-title":"Long-term outcomes of adolescents and young adults identified by metabolic newborn screening","volume":"155","author":"M\u00fctze","year":"2025","journal-title":"Pediatrics."},{"issue":"5","key":"2026101308522408600_r20","doi-asserted-by":"crossref","first-page":"e20200444","DOI":"10.1542\/peds.2020-0444","article-title":"Long-term outcomes of individuals with metabolic diseases identified through newborn screening","volume":"146","author":"M\u00fctze","year":"2020","journal-title":"Pediatrics."},{"key":"2026101308522408600_r21","article-title":"Kinder-Richtlinie","author":"Gemeinsamer Bundesausschuss"},{"issue":"20","key":"2026101308522408600_r22","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1021\/acs.analchem.9b03127","article-title":"Analysis of glutamine deamidation: products, pathways, and kinetics","volume":"91","author":"Riggs","year":"2019","journal-title":"Anal Chem."},{"issue":"1","key":"2026101308522408600_r23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0969141314525367","article-title":"Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders","volume":"21","author":"Golbahar","year":"2014","journal-title":"J Med Screen."},{"issue":"1","key":"2026101308522408600_r24","doi-asserted-by":"crossref","first-page":"e15072","DOI":"10.1111\/ped.15072","article-title":"Stability of amino acids, free and acyl-carnitine in stored dried blood spots","volume":"64","author":"Shimada","year":"2022","journal-title":"Pediatr Int."},{"issue":"6","key":"2026101308522408600_r25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jimd.12671","article-title":"Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77\u00a0million samples","volume":"46","author":"Maier","year":"2023","journal-title":"J Inherit Metab Dis."},{"key":"2026101308522408600_r26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cca.2014.05.016","article-title":"Development of an assay to simultaneously measure orotic acid, amino acids, and acylcarnitines in dried blood spots","volume":"436","author":"Held","year":"2014","journal-title":"Clin Chim Acta."},{"key":"2026101308522408600_r27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cca.2013.12.020","article-title":"Towards newborn screening for ornithine transcarbamylase deficiency: fast non-chromatographic orotic acid quantification from dried blood spots by tandem mass spectrometry","volume":"430","author":"Janzen","year":"2014","journal-title":"Clin Chim Acta."},{"issue":"3","key":"2026101308522408600_r28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ymgme.2009.06.011","article-title":"Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening","volume":"98","author":"Ficicioglu","year":"2009","journal-title":"Mol Genet Metab."},{"issue":"11","key":"2026101308522408600_r29","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/acn3.51668","article-title":"Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency","volume":"9","author":"Scharre","year":"2022","journal-title":"Ann Clin Transl Neurol."},{"issue":"9","key":"2026101308522408600_r30","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/acn3.50886","article-title":"Early prediction of phenotypic severity in citrullinemia type 1","volume":"6","author":"Zielonka","year":"2019","journal-title":"Ann Clin Transl Neurol."},{"issue":"5","key":"2026101308522408600_r31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/humu.23983","article-title":"From genotype to phenotype: Early prediction of disease severity in argininosuccinic aciduria","volume":"41","author":"Zielonka","year":"2020","journal-title":"Hum Mutat."},{"issue":"15","key":"2026101308522408600_r32","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.3390\/nu15153355","article-title":"Combined newborn screening allows comprehensive identification also of attenuated phenotypes for methylmalonic acidurias and homocystinuria","volume":"15","author":"Schnabel","year":"2023","journal-title":"Nutrients."},{"issue":"2","key":"2026101308522408600_r33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10545-015-9901-1","article-title":"Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders--review and meta-analysis of observational studies published over more than 35\u00a0years","volume":"39","author":"Burgard","year":"2016","journal-title":"J Inherit Metab Dis."},{"issue":"5","key":"2026101308522408600_r34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10545-016-9938-9","article-title":"Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders","volume":"39","author":"Posset","year":"2016","journal-title":"J Inherit Metab Dis."},{"key":"2026101308522408600_r35","doi-asserted-by":"crossref","first-page":"102405","DOI":"10.1016\/j.eclinm.2023.102405","article-title":"Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial","volume":"68","author":"Russo","year":"2024","journal-title":"EClinicalMedicine."},{"issue":"4","key":"2026101308522408600_r36","doi-asserted-by":"crossref","first-page":"e70066","DOI":"10.1002\/jimd.70066","article-title":"Long-term efficacy and tolerability of pegzilarginase in arginase 1 deficiency: results of two international multicentre open-label extension studies","volume":"48","author":"McNutt","year":"2025","journal-title":"J Inherit Metab Dis."},{"issue":"1","key":"2026101308522408600_r37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jimd.12609","article-title":"Gene therapy for urea cycle defects: an update from historical perspectives to future prospects","volume":"47","author":"Duff","year":"2024","journal-title":"J Inherit Metab Dis."},{"key":"2026101308522408600_r38","article-title":"Clinical study of DTX301 AAV-mediated gene transfer for ornithine transcarbamylase (OTC) deficiency","year":"2025"},{"key":"2026101308522408600_r39","article-title":"iECURE receives FDA orphan drug designation for GTP-506, an investigational gene editing product candidate for the treatment of ornithine transcarbamylase (OTC) deficiency","author":"iECURE","year":"2022"},{"issue":"1","key":"2026101308522408600_r40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-022-02226-8","article-title":"Arginase 1 Deficiency: using genetic databases as a tool to establish global prevalence","volume":"17","author":"Catsburg","year":"2022","journal-title":"Orphanet J Rare Dis."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-074052\/1945638\/pediatrics.2025074052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-074052\/1945638\/pediatrics.2025074052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:52:34Z","timestamp":1791895954000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/158\/2\/e2025074052\/208296\/Newborn-Screening-for-Urea-Cycle-Disorders-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,7,22]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2025-074052","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"e2025074052"}}